Literature DB >> 3621616

Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.

K A Edyvane, C M Hibberd, R M Harnett, V R Marshall, R L Ryall.   

Abstract

Removal of macromolecules with Mr greater than 10,000 had no discernible effect on the detectable nucleation of calcium oxalate crystals from undiluted human urine, but promoted the deposition of crystalline material and markedly increased the degree of aggregation of the precipitated crystals. Calcium oxalate crystals and crystal aggregates precipitated from ultrafiltered urine were, on average, 68% larger than those deposited from whole urine. These findings suggest that urinary macromolecules play a key role in preventing calcium oxalate kidney stone disease by inhibiting the formation of large crystal aggregates and thereby reducing the probability of particle retention in the kidney tubules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621616     DOI: 10.1016/0009-8981(87)90353-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle; F Hering; H Seiler
Journal:  Urol Res       Date:  1996

Review 2.  Intratubular crystallization events.

Authors:  D J Kok
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle
Journal:  Experientia       Date:  1995-11-15

4.  Effect of urinary macromolecules on aggregation of calcium oxalate in recurrent calcium stone formers and healthy.

Authors:  S Ebisuno; Y Kohjimoto; T Yoshida; T Ohkawa
Journal:  Urol Res       Date:  1993

5.  Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin.

Authors:  K Suzuki; M Moriyama; C Nakajima; K Kawamura; K Miyazawa; R Tsugawa; N Kikuchi; K Nagata
Journal:  Urol Res       Date:  1994

6.  Isolation of a crystal matrix protein associated with calcium oxalate precipitation in vacuoles of specialized cells.

Authors:  Xingxiang Li; Dianzhong Zhang; Valerie J Lynch-Holm; Thomas W Okita; Vincent R Franceschi
Journal:  Plant Physiol       Date:  2003-10       Impact factor: 8.340

7.  The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.

Authors:  E M Worcester; J L Sebastian; J G Hiatt; A M Beshensky; J A Sadowski
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

8.  Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

Authors:  S Sørensen; S J Justesen; A H Johnsen
Journal:  Urol Res       Date:  1995

9.  Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.

Authors:  S R Qiu; A Wierzbicki; C A Orme; A M Cody; J R Hoyer; G H Nancollas; S Zepeda; J J De Yoreo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

10.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.

Authors:  F Atmani; B Lacour; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.